Article

FDA approves excimer laser for refractive surgery

The FDA approved Bausch & Lomb's 100 Hz excimer laser (217z100) as part of the company's Zyoptix personalized laser vision-correction system.

The FDA approved Bausch & Lomb’s 100 Hz excimer laser (217z100) as part of the company’s Zyoptix personalized laser vision-correction system.

In both standard and custom treatment modes, the 217z100 laser operates at twice the speed of Bausch & Lomb’s current system on the U.S. market, according to the company.

The laser will be commercially available by July 2006. Also, practices with the current Zyoptix system will be given an option to upgrade to the faster technology.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.